Glaxo eyes boost from new products

Drug maker GlaxoSmithKline today said a pipeline of new products would help sustain growth as it revealed a rise in underlying sales.

The pharmaceuticals company said a range of new drugs – including for epilepsy, lupus and rotavirus – should help it boost its margins in the year ahead.